About
Bio
BioPharm Insight (BPI) is a team of investigative journalists, and owned by the Financial Times Group. The editorial team operates out of New York, London and Shanghai and covers a pipeline of events by aggregating and reviewing data about thousands of upcoming pivotal drug development events, plus equity research, Wall Street data, industry news releases, and historical coverage. The news operation is only one part of an online business intelligence system that also includes market analytics, and a database of industry contacts.
The team covers everything in healthcare, from drug development and research, partnerships/licensing, M&A, regulatory, reimbursement, medical devices, healthcare services, CROs, CMOs, among others.
The majority of their journalists have graduate degrees in the sciences, or years of scientific reporting. They are versed in understanding clinical trials data, as well as deciphering statistics. This enables BPI to uncover news and build relationship with doctors, scientists, company executives and other opinion leaders.
BioPharm Insight is published by Infinata, part of the Financial Times Group of companies and a division of Pearson plc.
BioPharm Insight does not provide user/circulation figures.
Email
email@cision.one
Website
site@cision.one
Social media
Location
United States of America
Frequency
upgrade
Circulation
upgrade
Sectors
News
Bio
BioPharm Insight (BPI) is a team of investigative journalists, and owned by the Financial Times Group. The editorial team operates out of New York, London and Shanghai and covers a pipeline of events by aggregating and reviewing data about thousands of upcoming pivotal drug development events, plus equity research, Wall Street data, industry news releases, and historical coverage. The news operation is only one part of an online business intelligence system that also includes market analytics, and a database of industry contacts. The team covers everything in healthcare, from drug development and research, partnerships/licensing, M&A, regulatory, reimbursement, medical devices, healthcare services, CROs, CMOs, among others. The majority of their journalists have graduate degrees in the sciences, or years of scientific reporting. They are versed in understanding clinical trials data, as well as deciphering statistics. This enables BPI to uncover news and build relationship with doctors, scientists, company executives and other opinion leaders. BioPharm Insight is published by Infinata, part of the Financial Times Group of companies and a division of Pearson plc. BioPharm Insight does not provide user/circulation figures.
Website
Social media
Location
Frequency
Circulation
Sectors
News
Most recent articles by GlobalData Pharma Investigative News - USA, NY, New York Bureau
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Explore outlets similar to GlobalData Pharma Investigative News - USA, NY, New York Bureau
-
The New York TimesThe New York Times offers the latest news from around the world. It has several different editions for Eastern and national regions. In addition, the paper gets much of its content and reporting from its many bureaus. The foreign desk oversees correspondents and stringers around the world. Daily deadlines are usually between 5pm and 6pm ET. The paper does not accept artwork. The lead time for news coverage is one day to one week, the lead time for special section features is three weeks. The lead time for advertising is 30 days.
View
BBC NewsBBC News aims to provide news for a national and international audience. It is available on Freeview, Sky channel 503 and on BBC iPlayer.
View
The Washington PostThe Washington Post focuses on news from the nation's capital, including national business, political issues, commerce, federal regulations and finance. There is also coverage of sports, entertainment, features, local and world news. Lead times vary.
View
The GuardianLaunched in 1821 as the Manchester Guardian, The Guardian is published by the Guardian News & Media Ltd daily and is aimed at readers nationwide. Covers news, sport, culture, lifestyle, environment, society, science, technology, global development and business. It also has a sister publication, The Observer.
View
The TelegraphLaunched in 1855, The Telegraph is published by the Telegraph Media Group Limited daily and is aimed at readers nationwide. Covers news, lifestyle, sport, travel, culture, business., women, men, food & drink, technology, motoring, education, fashion, money, film, luxury and jobs. It also has a sister newspaper, The Sunday Telegraph.
ViewUse CisionOne to find more relevant outletsExplore journalists that write for GlobalData Pharma Investigative News - USA, NY, New York Bureau
Contact us to find more relevant journalistsContact GlobalData Pharma Investigative News - USA, NY, New York Bureau and get access to over 850K accurate, up-to-date media profiles.
Discover the stories that impact your brand. In realtime.
CisionOne delivers relevant news, trends and conversations that matter to your brand with the world’s most comprehensive media monitoring service across Print, Online, TV, Radio, Social, Magazines, Podcasts and more.
